| COF |
Report |
Adjusted diluted EPS |
BEAT |
pred ~$4.98 vs. cons $4.89 |
MEDIUM |
| COF |
Report |
Total net revenue |
BEAT |
pred ~$15.87B vs. cons $15.69B |
MEDIUM |
| COF |
Report |
Provision for credit losses |
BEAT |
pred ~$3.80B vs. cons $4.05B |
MEDIUM |
| COF |
Guide |
Discover total synergies |
UNCHANGED |
guide ~$2.50B vs. cons $2.50B (mid-2027) |
HIGH |
| COF |
Guide |
Net interest margin |
BETTER |
guide ~8.20% vs. cons 8.15% (2H26) |
MEDIUM |
| COF |
Guide |
Implicit adjusted EPS outlook |
LOWER |
guide ~$9.45 vs. cons $9.77 (2H26) |
MEDIUM |
| COF |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.2% |
— |
MEDIUM |
| COF |
Return |
5-day cumulative residual |
+0.7% (FADE) |
Benign credit, NIM recovery and debit-network synergies support the initial beat, but heavier Brex, travel, marketing and integration investment implies ~$9.45 of 2H26 adjusted EPS versus ~$9.77 consensus, pulling out-period estimates lower and causing most of the day-1 gain to fade. |
MEDIUM |